
The civil rights leader Rev. Jesse Jackson has been hospitalized, the Rainbow PUSH Coalition announced Wednesday evening.
Jackson, 84, has been admitted to the hospital and is under observation for progressive supranuclear palsy, a neurodegenerative condition, which he has been managing for a decade, the organization said in a statement.
"The family appreciates all prayers at this time," the group said.
Jackson was originally diagnosed with Parkinson's disease, however his PSP condition was confirmed in April, the organization said.
PSP is a rare neurological disorder which affects body movements, walking and balance, and eye movements, according to the National Institutes of Health. It is caused by damage to nerve cells in parts of the brain.
Jackson, a protege to the Rev. Martin Luther King Jr. who rose to prominence as one of the nation's foremost civil rights leaders and twice ran for U.S. president, stepped down in 2023 from the leadership of the Rainbow PUSH Coalition, which he founded.
LATEST POSTS
- 1
Step by step instructions to Advance the Eco-friendliness of Your Kona SUV - 2
Former United Launch Alliance CEO Tory Bruno joins competitor Blue Origin for national security projects - 3
Surveys of Thrillers That Re-imagined the Class - 4
Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance - 5
I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
Opening Innovativeness: Moving Thoughts and Tasks
'Crammed into a cell with vermin at New Year'
Flu season is just beginning, but doctors are already on high alert
Revealing the Incomparable Realms: An Excursion through Power and Inheritance
Great DSLR Cameras for Photography Devotees
Electric discovery on Mars! Scientists find tiny lightning bolts coming from Red Planet dust clouds
6 Hints to Upgrade Your Charm, In addition to Your Mentality
Winter storm warnings issued across Northeast as up to 9 inches of snow forecast; deadly atmospheric river in California snarls travel
Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research













